Cepheid
Michael Chen has a diverse background in bioengineering and holds a PhD, MS, and BS in the field. Michael has held various technical and managerial roles at companies like Cepheid, Verily Life Sciences, Theranos, and Quantapore Inc. Currently, Michael serves as the VP of Technology and Innovation at Cepheid, overseeing early stage engineering research in molecular diagnostics. Prior to this, Michael was a Senior Director at Cepheid, a Technical Lead and Manager at Verily Life Sciences, and a Team Lead at Theranos. During their time at Stanford University, Michael worked as a Visiting Scholar at the Dept. of Electrical Engineering.
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.